This blog post dives into the fascinating and often-overlooked area of the Psychological impact of GLP-1 medications , exploring how these therapies change your internal dialogue around food
They have shown effects on reduced gluconeogenesis [86], inflammatory markers [109], and insulin resistance [110,111,112]
10.1007/s11419-021-00597-4 43 RahnemaC
Intramuscular (IM) medication is administered through injections into the muscle, allowing for rapid and effective absorption of nutrients and medications into the body
A recent study in Nature Medicine reported that GLP-1 receptor agonists are associated with lower risk of various health conditions, including coagulation disorders, heart conditions, infectious diseases and neurocognitive disorders like Alzheimers disease